XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Reporting (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting |
Schedule of certain segment information | The following table includes certain segment information for the periods presented (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended September 30, | ​ | Nine Months Ended September 30,
​ | ​ | 2025 | ​ | 2024 | ​ | 2025 | ​ | 2024
Grant and award revenue | ​ | $ | 1,159 | ​ | $ | 2,973 | ​ | $ | 3,819 | ​ | $ | 3,939
Operating expenses | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Research and development expenses: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
AP-PA02: Non-Cystic Fibrosis Bronchiectasis | ​ | ​ | 190 | ​ | ​ | 1,858 | ​ | ​ | (98) | ​ | ​ | 5,459
AP-PA02: Cystic Fibrosis | ​ | ​ | - | ​ | ​ | - | ​ | ​ | 25 | ​ | ​ | 235
AP-SA02: Bacteremia | ​ | ​ | 404 | ​ | ​ | 1,618 | ​ | ​ | 2,067 | ​ | ​ | 2,752
AP-SA02: Prosthetic Joint Infection | ​ | ​ | - | ​ | ​ | - | ​ | ​ | 2 | ​ | ​ | 8
Expenses not allocated by projects* | ​ | ​ | 545 | ​ | ​ | 726 | ​ | ​ | 1,657 | ​ | ​ | 1,903
Total external research and development expenses | ​ | ​ | 1,139 | ​ | ​ | 4,202 | ​ | ​ | 3,653 | ​ | ​ | 10,357
Research and development personnel expenses | ​ | ​ | 2,287 | ​ | ​ | 2,874 | ​ | ​ | 6,893 | ​ | ​ | 8,296
Other research and development expenses | ​ | ​ | 2,398 | ​ | ​ | 2,409 | ​ | ​ | 7,101 | ​ | ​ | 7,322
Total research and development expenses | ​ | ​ | 5,824 | ​ | ​ | 9,485 | ​ | ​ | 17,647 | ​ | ​ | 25,975
General and administrative expenses: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
General and administrative personnel expenses | ​ | ​ | 1,141 | ​ | ​ | 1,273 | ​ | ​ | 3,733 | ​ | ​ | 3,778
Other general and administrative expenses | ​ | ​ | 1,970 | ​ | ​ | 1,971 | ​ | ​ | 5,250 | ​ | ​ | 6,083
Total general and administrative expenses | ​ | ​ | 3,111 | ​ | ​ | 3,244 | ​ | ​ | 8,983 | ​ | ​ | 9,861
Total operating expenses | ​ | ​ | 8,935 | ​ | ​ | 12,729 | ​ | ​ | 26,630 | ​ | ​ | 35,836
Operating loss | ​ | ​ | (7,776) | ​ | ​ | (9,756) | ​ | ​ | (22,811) | ​ | ​ | (31,897)
Other income (expense), net | ​ | ​ | (18,899) | ​ | ​ | 4,275 | ​ | ​ | (26,690) | ​ | ​ | 10,381
Net loss | ​ | $ | (26,675) | ​ | $ | (5,481) | ​ | $ | (49,501) | ​ | $ | (21,516)
​

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration